Literature DB >> 18770308

Procedures for the haemagglutination and the haemagglutination inhibition tests for avian infectious bronchitis virus.

D J Alexander1, N J Chettle.   

Abstract

Various aspects of production, storage and stability of the haemagglutination (HA) activity of infectious bronchitis virus (IBV) were studied. From the results obtained, a standard procedure for the production of IBV, HA and the HA and haemagglutination inhibition (HI) tests is suggested. The main points of the suggested procedure are: (1) the virus should be concentrated but not purified; (2) the virus should be treated with phospho-lipase C type 1 (PLC), at a final concentration of one unit/ml, for two hours at 37 degrees C; (3) the virus should be stored at 4 degrees C after PLC treatment; (4) HA and HI test plates should be kept at 4 degrees C and read 45-60 min after the addition of chicken red blood cells. Using the recommended standard procedure the HA and HI tests for IBV were as reproducible as the HA and HI tests for Newcastle disease virus.

Entities:  

Year:  1977        PMID: 18770308     DOI: 10.1080/03079457708418208

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  19 in total

1.  A new typing method for the avian infectious bronchitis virus using polymerase chain reaction and restriction enzyme fragment length polymorphism.

Authors:  Z Lin; A Kato; Y Kudou; S Ueda
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Ameliorative effect of synthetic γ-aminobutyric acid (GABA) on performance traits, antioxidant status and immune response in broiler exposed to cyclic heat stress.

Authors:  Naila Chand; Sher Muhammad; Rifat Ullah Khan; Ibrahim Abdullah Alhidary; Zia Ur Rehman
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-15       Impact factor: 4.223

3.  Antigen requirements and specificity of a microplate enzyme-linked immunosorbent assay (ELISA) for detecting infectious bronchitis viral antibodies in chicken serum.

Authors:  A Soula; Y Moreau
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

4.  Protection conferred by live infectious bronchitis vaccine viruses against variant Middle East IS/885/00-like and IS/1494/06-like isolates in commercial broiler chicks.

Authors:  Faez Awad; Anne Forrester; Matthew Baylis; Stephane Lemiere; Kannan Ganapathy; Hussein Aly Hussien; Ilaria Capua
Journal:  Vet Rec Open       Date:  2015-09-09

5.  Effects of dietary supplementation of mannan-oligosaccharide on virus shedding in avian influenza (H9N2) challenged broilers.

Authors:  T Akhtar; G Ara; N Ali; F Ud Din Mufti; M Imran Khan
Journal:  Iran J Vet Res       Date:  2016       Impact factor: 1.376

6.  Polymorphisms of the Chicken Mx Gene Promoter and Association with Chicken Embryos' Susceptibility to Virulent Newcastle Disease Virus Challenge.

Authors:  Fulgence N Mpenda; Christian T Keambou; Martina Kyallo; Roger Pelle; Sylvester L Lyantagaye; Joram Buza
Journal:  Biomed Res Int       Date:  2019-10-03       Impact factor: 3.411

7.  Hemagglutination with transmissible gastroenteritis virus.

Authors:  M Noda; H Yamashita; F Koide; K Kadoi; T Omori; M Asagi; Y Inaba
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

8.  Taishan Pinus massoniana pollen polysaccharide inhibits subgroup J avian leucosis virus infection by directly blocking virus infection and improving immunity.

Authors:  Cuilian Yu; Kai Wei; Liping Liu; Shifa Yang; Liping Hu; Peng Zhao; Xiuyan Meng; Mingxu Shao; Chuanwen Wang; Lijun Zhu; Hao Zhang; Yang Li; Ruiliang Zhu
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

9.  Physicochemical properties of transmissible gastroenteritis virus hemagglutinin.

Authors:  M Noda; F Koide; M Asagi; Y Inaba
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

10.  The pathogenesis of nephritis in chickens induced by infectious bronchitis virus.

Authors:  K T Chong; K Apostolov
Journal:  J Comp Pathol       Date:  1982-04       Impact factor: 1.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.